About
Technology
Issues
FAQ
Links
Official Page
Double‐blind, randomised, placebo‐controlled crossover trial to evaluate the clinical efficacy of rifaximin in patients with moderate to severe active Crohn’s disease
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.